WELL Health Technologies Corp.
WELL.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 672.06M | 703.99M | 671.85M | 621.40M | 574.90M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 672.06M | 703.99M | 671.85M | 621.40M | 574.90M |
| Cost of Revenue | 406.07M | 393.13M | 373.04M | 333.44M | 299.06M |
| Gross Profit | 266.00M | 310.86M | 298.82M | 287.95M | 275.84M |
| SG&A Expenses | 277.55M | 280.97M | 276.31M | 269.87M | 205.21M |
| Depreciation & Amortization | 52.72M | 50.06M | 48.77M | 46.57M | 45.02M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 844.55M | 832.38M | 806.33M | 758.10M | 549.29M |
| Operating Income | -733.90K | 43.36M | 37.27M | 35.05M | 25.61M |
| Income Before Tax | 7.44M | 69.12M | 120.51M | 36.36M | 14.24M |
| Income Tax Expenses | -14.38M | -175.60K | -991.20K | 1.85M | 2.12M |
| Earnings from Continuing Operations | 21.82 | 69.30 | 121.50 | 34.51 | 12.12 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.20M | -15.55M | -13.89M | -12.84M | -12.25M |
| Net Income | 24.02M | 53.75M | 107.61M | 21.67M | -135.50K |
| EBIT | -733.90K | 43.36M | 37.27M | 35.05M | 25.61M |
| EBITDA | 52.60M | 97.95M | 90.57M | 86.15M | 62.88M |
| EPS Basic | 0.10 | 0.22 | 0.44 | 0.09 | 0.00 |
| Normalized Basic EPS | -0.16 | -0.07 | -0.08 | -0.08 | -0.06 |
| EPS Diluted | 0.11 | 0.25 | 0.47 | 0.13 | -0.01 |
| Normalized Diluted EPS | -0.16 | -0.07 | -0.08 | -0.08 | -0.06 |
| Average Basic Shares Outstanding | 961.80M | 978.39M | 967.69M | 957.07M | 946.11M |
| Average Diluted Shares Outstanding | 978.40M | 994.98M | 984.28M | 957.07M | 946.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |